What I've been told (by an Israeli analyst who attended the meeting) Eyal Desheh said is they don't manufacture enoxaparin in-house but have a partner.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.